MedPath

ELELYSO

ELELYSO

Approved
DIN Number

02425637

Drug Class

Human

Market Date

Sep 8, 2014

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02425637
AIG Number0155691001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
A16AB11 TALIGLUCERASE ALFA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TALIGLUCERASE ALFAActive
Strength: 200 UNIT / VIAL
Monograph: TALIGLUCERASE ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.